Given its key role in promoting expression of IL-8 by various cell types, including tumor cells (Inozume et al., 2009) that promote influx of neutrophils/MDSCs into the TME (He et al., 2010), IL-17A also represents a prominent target for the control of neutrophilic inflammation. The gene discussed is CXCL8; the disease is neoplasm.